Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto - 9-MTH group results

Feb 9 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              124.11              111.42           165.00     
                   (+11.4 pct)         (-7.4 pct)       (+6.7 pct)   
  Operating           15.61               12.39            16.80     
                   (+25.9 pct)         (+4.5 pct)       (+8.7 pct)   
  Recurring           15.75               12.97            16.90     
                   (+21.5 pct)         (+6.1 pct)       (+5.9 pct)   
  Net                 10.10                8.41            10.50     
                   (+20.1 pct)         (+7.8 pct)       (+4.9 pct)   
  EPS               88.68 yen           73.93 yen        92.17 yen   
  EPS Diluted       88.31 yen           73.62 yen                    
  Ann Div                               21.00 yen        22.00 yen   
  -Q2 div           11.00 yen           10.00 yen                    
  -Q4 div                               11.00 yen        11.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Rohto Pharmaceutical

See all news